Table 2.
SF-36 categories and DHI scores in patient who received dimenhydrinate before and after treatment
| Variables | Mean (SD) | Test statistics* | P-value | |
|---|---|---|---|---|
| Before treatment | After treatment | |||
| Categories in SF-36 | ||||
| General health perceptions | 45.5 (17.8) | 75.2 (18.1) | − 7.403 | 0.0001 |
| Vitality | 46.2 (14.6) | 74.5 (14.9) | − 8.544 | 0.0001 |
| Physical functioning | 43.8 (16.5) | 70.7 (15.3) | − 6.707 | 0.0001 |
| Role limitation due to physical health problems | 35.8 (29.1) | 68.3 (23.6) | − 4.187¥ | 0.0001¥ |
| Bodily pain | 39.2 (15.9) | 70.7 (14.2) | − 9.056 | 0.0001 |
| Emotional well-being | 31.2 (20.5) | 68.7 (18.9) | − 7.636 | 0.0001 |
| Role limitation due to emotional problems | 34.4 (34.4) | 71.1 (33.6) | − 3.635¥ | 0.0001¥ |
| Social functioning | 47.8 (16.6) | 55.1 (26.4) | − 1.186 | 0.245 |
| DHI | 59.8 (21.6) | 29.9 (14) | − 6.531 | 0.0001 |
*Paired t-test or Wilcoxon
¥Wilcoxon test